Literature DB >> 7635150

Kinetics of streptolysin O self-assembly.

M Palmer1, A Valeva, M Kehoe, S Bhakdi.   

Abstract

Streptolysin O is a member of a family of membrane-damaging toxins that bind to cell membranes containing cholesterol and then polymerize to form large pores. We have examined the kinetics of toxin action using 125I-labelled streptolysin O. Binding of toxin monomers to membranes displays first-order kinetics and is reversible; the rate of desorption from red cells shows a marked dependence on temperature. To study oligomerization, toxin was bound to erythrocytes at 0 degrees C. Oligomer formation was then triggered by a sudden temperature shift and stopped by solubilization of membranes with deoxycholate. While at moderately high streptolysin O concentrations oligomerization behaves as a reaction of second order, the kinetic pattern changes with increasing toxin concentration. We show that this can be accounted for by the assumption of a two-step reaction mechanism: two membrane-bound monomers first associate into a start complex, which then is rapidly extended by the sequential addition of further monomers up to the final oligomer size.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7635150     DOI: 10.1111/j.1432-1033.1995.tb20711.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Dissecting the self-assembly kinetics of multimeric pore-forming toxins.

Authors:  A A Lee; M J Senior; M I Wallace; T E Woolley; I M Griffiths
Journal:  J R Soc Interface       Date:  2016-01       Impact factor: 4.118

2.  Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes.

Authors:  Ehsan Sarafraz-Yazdi; Wilbur B Bowne; Victor Adler; Kelley A Sookraj; Vernon Wu; Vadim Shteyler; Hunaiz Patel; William Oxbury; Paul Brandt-Rauf; Michael E Zenilman; Josef Michl; Matthew R Pincus
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

Review 3.  Eating for good health: linking autophagy and phagocytosis in host defense.

Authors:  Miguel A Sanjuan; Douglas R Green
Journal:  Autophagy       Date:  2008-06-03       Impact factor: 16.016

4.  Assembly mechanism of the oligomeric streptolysin O pore: the early membrane lesion is lined by a free edge of the lipid membrane and is extended gradually during oligomerization.

Authors:  M Palmer; R Harris; C Freytag; M Kehoe; J Tranum-Jensen; S Bhakdi
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

5.  Bacterial cytolysin perturbs round window membrane permeability barrier in vivo: possible cause of sensorineural hearing loss in acute otitis media.

Authors:  F Engel; R Blatz; R Schliebs; M Palmer; S Bhakdi
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Formation of ring-shaped structures on erythrocyte membranes after treatment with botulinolysin, a thiol-activated hemolysin from Clostridium botulinum.

Authors:  K Sekiya; H Danbara; Y Futaesaku; A Haque; N Sugimoto; M Matsuda
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

7.  Electron microscopic evaluation of a two-step theory of pore formation by streptolysin O.

Authors:  K Sekiya; H Danbara; K Yase; Y Futaesaku
Journal:  J Bacteriol       Date:  1996-12       Impact factor: 3.490

8.  F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability.

Authors:  Jingjing Kang; Jie Gao; Wenwu Yao; Lin Kang; Shan Gao; Hao Yang; Bin Ji; Ping Li; Jing Liu; Jiahao Yao; Wenwen Xin; Baohua Zhao; Jinglin Wang
Journal:  Hum Vaccin Immunother       Date:  2017-03-17       Impact factor: 3.452

Review 9.  Perfringolysin O structure and mechanism of pore formation as a paradigm for cholesterol-dependent cytolysins.

Authors:  Benjamin B Johnson; Alejandro P Heuck
Journal:  Subcell Biochem       Date:  2014

10.  Measuring kinetic drivers of pneumolysin pore structure.

Authors:  Robert J C Gilbert; Andreas F-P Sonnen
Journal:  Eur Biophys J       Date:  2016-02-23       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.